Michael Benkowitz - Net Worth and Insider Trading

Michael Benkowitz Net Worth

The estimated net worth of Michael Benkowitz is at least $974,441 dollars as of 2024-11-29. Michael Benkowitz is the PRESIDENT AND COO of United Therapeutics Corp and owns about 2,577 shares of United Therapeutics Corp (UTHR) stock worth over $974,441. Details can be seen in Michael Benkowitz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Benkowitz has not made any transactions after 2024-11-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael Benkowitz

To

Michael Benkowitz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Benkowitz owns 1 companies in total, including United Therapeutics Corp (UTHR) .

Click here to see the complete history of Michael Benkowitz’s form 4 insider trades.

Insider Ownership Summary of Michael Benkowitz

Ticker Comapny Transaction Date Type of Owner
UTHR United Therapeutics Corp 2024-11-18 President and COO

Michael Benkowitz Latest Holdings Summary

Michael Benkowitz currently owns a total of 1 stock. Michael Benkowitz owns 2,577 shares of United Therapeutics Corp (UTHR) as of November 25, 2024, with a value of $974,441.

Latest Holdings of Michael Benkowitz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
UTHR United Therapeutics Corp 2024-11-25 2,577 378.13 974,441

Holding Weightings of Michael Benkowitz


Michael Benkowitz Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Benkowitz has made a total of 7 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in United Therapeutics Corp is the sale of 10,000 shares on November 25, 2024, which brought Michael Benkowitz around $4 Million.

Insider Trading History of Michael Benkowitz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Benkowitz Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Benkowitz Ownership Network

Ownership Network List of Michael Benkowitz

No Data

Ownership Network Relation of Michael Benkowitz

Insider Network Chart

Michael Benkowitz Owned Company Details

What does United Therapeutics Corp do?

Who are the key executives at United Therapeutics Corp?

Michael Benkowitz is the President and COO of United Therapeutics Corp. Other key executives at United Therapeutics Corp include EVP & General Counsel Paul A Mahon , CFO and Treasurer James Edgemond , and director & Chief Executive Officer Martine A Rothblatt .

United Therapeutics Corp (UTHR) Insider Trades Summary

Over the past 18 months, Michael Benkowitz made 6 insider transaction in United Therapeutics Corp (UTHR) with a net sale of 99,700. Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 707,954 shares made by Martine A Rothblatt , a net sale of 130,200 shares made by Paul A Mahon , and a net sale of 133,718 shares made by James Edgemond .

In summary, during the past 3 months, insiders sold 177,815 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 177,815 shares. During the past 18 months, 1,143,835 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,143,835 shares.

United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

United Therapeutics Corp Insider Transactions

No Available Data

Michael Benkowitz Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Benkowitz. You might contact Michael Benkowitz via mailing address: C/o United Therapeutics Corp, 1040 Spring Street, Silver Spring Md 20910.

Discussions on Michael Benkowitz

No discussions yet.